Vienna General Hospital and the “Narrenturm” – “Fool’S Tower” Vienna General Hospital Was Established in 1784 by the Order of Emperor Joseph II
Barish et al Breast Cancer and Cardiovascular Disease 43. Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon az-ca/downloads/productinformation/arimidex-product-monograph-en. KE, Giordano SH, Hudis CA, Rowden D, Solky AJ, Stearns V, Winer EP, pdf. Accessed December 11, 2018. Griggs JJ. Adjuvant endocrine therapy for women with hormone recep- 47. Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa tor-positive breast cancer: american society of clinical oncology clinical S, Azoulay L. Cardiotoxicity of aromatase inhibitors and tamoxifen in post- practice guideline focused update. J Clin Oncol. 2014;32:2255–2269. doi: menopausal women with breast cancer: a systematic review and meta- 10.1200/JCO.2013.54.2258 analysis of randomized controlled trials. Ann Oncol. 2017;28:487–496. 44. Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of adjuvant en- doi: 10.1093/annonc/mdw673 docrine therapy in postmenopausal breast cancer patients: a systematic 48. Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, Xu X, Barac review and meta-analysis. J Natl Cancer Inst. 2011;103:1299–1309. doi: A, Chlebowski RT. Cardiovascular Disease After Aromatase Inhibitor Use. STATE OF THE ART STATE 10.1093/jnci/djr242 JAMA Oncol. 2016;2:1590–1597. doi: 10.1001/jamaoncol.2016.0429 45. Buzdar A, Howell A, Cuzick J, Wale C, Distler W, Hoctin-Boes G, Hough- 49. Coates AS, Keshaviah A, Thürlimann B, Mouridsen H, Mauriac L, Forbes ton J, Locker GY and Nabholtz JM. Comprehensive side-effect pro- JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del file of anastrozole and tamoxifen as adjuvant treatment for early-stage Mastro L, Smith I, Chirgwin J, Nogaret JM, Pienkowski T, Wardley A, Ja- breast cancer: long-term safety analysis of the ATAC trial.
[Show full text]